Aldactone therapy in a peritoneal dialysis patient (multiple letters) [3]

Nephrology Dialysis Transplantation

Volumn 18, Issue 6, 2003, Pages 1232-1233

  Fenwick, Sean ^b   Bell, Gordon M ^b   Azar, Raymond ^c   Hogede, Laurence ^c   Carru, Valerie ^c   Hausmann, Michael J ^a   Liel Cohen, Noah ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c Dunkerque General Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; LOOP DIURETIC AGENT; POTASSIUM; SPIRONOLACTONE; TRANDOLAPRIL; ALDOSTERONE ANTAGONIST;

CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HEART INFARCTION; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; KIDNEY DISEASE; KIDNEY FAILURE; LETTER; MORTALITY; NONHUMAN; PERITONEAL DIALYSIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; ANIMAL; CHRONIC KIDNEY FAILURE; HEART LEFT VENTRICLE FUNCTION; NOTE; PHYSIOLOGY;

ANIMALS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERKALEMIA; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; SPIRONOLACTONE; VENTRICULAR FUNCTION, LEFT; ALDOSTERONE ANTAGONISTS;

EID: 0038684557     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg098     Document Type: Letter

References (0)